Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Sotac Pharmaceuticals Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Sotac Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Sotac Pharmaceutical - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Sotac Pharmaceutical - Resignation
-
Sotac Pharmaceutical - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Sotac Pharmaceutical - Appointment
-
Sotac Pharmaceutical - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Sotac Pharmaceutical - Updates
-
Sotac Pharmaceutical - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
-
Sotac Pharmaceutical - Reply to Clarification- Financial results
Key fundamentals
Evaluate the intrinsic value of Sotac Pharmaceuticals Ltd stock
Name | March-24 | March-23 | March-22 | March-21 | |
---|---|---|---|---|---|
Assets | 59.4405 | 31.6484 | 14.0094 | 10.8993 | |
Liabilities | 59.4405 | 31.6484 | 14.0094 | 10.8993 | |
Equity | 11.05 | 8.05 | 2.3 | 2.3 | |
Gross Profit | 10.1947 | 8.208 | 6.1353 | 2.8012 | |
Net Profit | 5.7488 | 4.4955 | 2.8786 | 0.8622 | |
Cash From Operating Activities | -19.7894 | 8.5361 | 6.3507 | 2.3507 | |
NPM(%) | 8.56 | 7.75 | 3.93 | 1.98 | |
Revenue | 67.105 | 57.9828 | 73.1517 | 43.4382 | |
Expenses | 56.9103 | 49.7748 | 67.0164 | 40.637 | |
ROE(%) | 12.19 | 9.53 | 6.1 | 1.82 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|
Peers
Other companies within the same industry or sector that are comparable to Sotac Pharmaceuticals Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 808.20 | -1.14 | 11.41 | 0.00 | 1321.50 | 1.42 |
Lotus Eye Hospital and Institute Ltd | 57.06 | -0.77 | 237.75 | 0.00 | 14.01 | 0.88 |
Vaishali Pharma Ltd | 12.12 | -5.90 | 606.00 | 0.00 | 2.31 | 0.00 |
Astec Lifesciences Ltd | 653.90 | -5.55 | 0.00 | 0.00 | -239.30 | 0.00 |
Company Info
The Company was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 ("Partnership Act") in the name and style of "M/s Sotac Pharmaceuticals", pursuant to a deed of partnership dated October 28, 2015. Thereafter "M/s. Sotac Pharmaceuticals" was converted from Partnership Firm to a Private Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of "Sotac Pharmaceuticals Private Limited" and received a certificate of incorporation dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat. Later on the Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of the Company held on November 12, 2022 and the name of the Company was changed to "Sotac Pharmaceuticals Limited". A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated November 22, 2022 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company is U24230GJ2015PLC085451.MAJOR EVENTS :2015- The Company was incorporated as a private limited company under the name "Sotac Pharmaceuticals Private Limited" Limited".2019- Recognised as "Fastest Growing Indian Company" with and Excellence Award by International Achievers Conference2021- Received "Indo Global award for Business Excellence"2022- The Company has acquired 53,25,000 Equity Shares in SOTAC Healthcare Private Limited making it subsidiary of the Company.- The Company has acquired 99,995 Equity Shares in SOTAC Research Private Limited making it wholly owned subsidiary of the Company.- The Company was converted into Public Limited Company under the name of "Sotac Pharmaceuticals Limited"- Received recognition as for "Fastest Expansion of Project" by Sanand Industries Association (SIA)- Recognized as one of the "Top 10 Pharma Contract Manufacturers in India" by India Pharma Outlook
The Company was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 ("Partnership Act") in the name and style of "M/s Sotac Pharmaceuticals", pursuant to a deed of partnership dated October 28, 2015. Thereafter "M/s. Sotac Pharmaceuticals" was converted from Partnership Firm to a Private Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of "Sotac Pharmaceuticals Private Limited" and received a certificate of incorporation dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat. Later on the Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of the Company held on November 12, 2022 and the name of the Company was changed to "Sotac Pharmaceuticals Limited". A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated November 22, 2022 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company is U24230GJ2015PLC085451.MAJOR EVENTS :2015- The Company was incorporated as a private limited company under the name "Sotac Pharmaceuticals Private Limited" Limited".2019- Recognised as "Fastest Growing Indian Company" with and Excellence Award by International Achievers Conference2021- Received "Indo Global award for Business Excellence"2022- The Company has acquired 53,25,000 Equity Shares in SOTAC Healthcare Private Limited making it subsidiary of the Company.- The Company has acquired 99,995 Equity Shares in SOTAC Research Private Limited making it wholly owned subsidiary of the Company.- The Company was converted into Public Limited Company under the name of "Sotac Pharmaceuticals Limited"- Received recognition as for "Fastest Expansion of Project" by Sanand Industries Association (SIA)- Recognized as one of the "Top 10 Pharma Contract Manufacturers in India" by India Pharma Outlook
Read More
Parent Organisation
Sotac Pharmaceuticals Ltd
Founded
18/12/2015
Managing Director
Mr.Sharadkumar Dashrathbhai Patel
NSE Symbol
SOTACSM
FAQ
The current price of Sotac Pharmaceuticals Ltd is
The 52-week high for Sotac Pharmaceuticals Ltd is
The market capitalization of Sotac Pharmaceuticals Ltd is currently
This value can fluctuate based on stock price movements and changes in the number of shares outstanding.To buy Sotac Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Sotac Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sotac Pharmaceuticals Ltd shares.
The CEO of Sotac Pharmaceuticals Ltd is Mr.Sharadkumar Dashrathbhai Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.